SaNOtize, the company behind an antiviral nasal spray for use against COVID-19, announced this week it has signed an agreement with Indian firm Glenmark Pharmaceuticals, to make the company’s breakthrough Nitric Oxide Nasal Spray (NONS) available in India and other Asian markets including Singapore, Malaysia, Hong Kong, Taiwan, Nepal, Brunei, Cambodia, Laos, Myanmar, Sri Lanka, Timor-Leste, and Vietnam.

Read more here.